Psychiatry Faculty Funded Research
Baylor College of Medicine is ranked among the leading medical schools in the country for research funding. The Menninger Department of Psychiatry has contributed to the school’s history of research excellence, as illustrated by the increase in National Institute of Health and private research funding support. Grants to the department more than doubled between 2005 and 2009. During 2010, the department exceeded $6,000,000 in grant funding, with the areas of addictions and mood disorders showing particularly strong growth.
A Prospective Evaluation of the Affective States Questionnaire Among Hospitalized Veterans in Inpatient Psychiatric Units
Dates: Aug. 1, 2010 - Jan. 31, 2012
Sponsor: Suicide Prevention International
PI: Rayan Al Jurdi, M.D.
E-mail: rayan.aljurdi@va.gov
Genetics of Functional Disability in Schizophrenia and Bipolar Illness
Dates: Jun. 1, 2010 - Jun. 1, 2014
Sponsor: Department of Veterans Affairs
PI: Rayan K. Al Jurdi, M.D.
E-mail: rayan.aljurdi@bcm.edu
Million Veteran Program: A Partnership With Veterans
Dates: Jun. 3, 2011 - Jun. 3, 2016
Sponsor: Department of Veterans Affairs
PI: Rayan K. Al Jurdi, M.D.
E-mail: rayan.aljurdi@bcm.edu
Behavioral Treatment of Anxiety in Parkinson's Disease (BehTA-PD): A Pilot Study
Dates: Sep. 2011 - Aug. 2012
Sponsor: Parkinson's Study Group and Parkinson's Disease Foundation Award
PI: Jessica Calleo, Ph.D.
E-mail: jcalleo@bcm.edu
Increasing Access and Implementation of Behavioral Treatments for Anxiety
and Depression in Rural Veterans with Parkinson's Disease
Dates: Jun. 2011 - May 2012
Sponsor: South Central MIRECC Pilot Program
PI: Jessica Calleo, Ph.D.
E-mail: jcalleo@bcm.edu
Neurobehavioral Metrics for the Assessment and Treatment of Depression
Dates: Jul. 1, 2010 – Jan. 31, 2015
Sponsor: National Institute of Mental Health
PI: Pearl Chiu, Ph.D.
E-mail: pchiu@cpu.bcm.edu
Neuroimaging Major Depression and Nicotine Dependence on Axes of Valuation
Dates: Jun. 30, 2010 - Jan. 31, 2015
Sponsor: National Institute of Mental Health
PI: Pearl Chiu, Ph.D.
E-mail: pchiu@cpu.bcm.edu
Bupropion and Varenicline Treatment: Smoking Cessation (Project Quit RX/Main - Conducted
at MD Anderson Cancer Center)
Dates: Apr. 2003 - Apr. 2012
Sponsor: National Institute on Drug Abuse
PI: Paul M. Cinciripini, Ph.D.
Co-I: Maher Karam-Hage, M.D.
E-mail: pcinciri@mdanderson.org and E-mail: karamhag@bcm.edu
Localized and Distributed Real-Time fMRI Approaches to Facilitate Self Control in Substance Abusers
Dates: Jul. 2010 - Jun. 2013
Sponsor: National Institute on Drug Abuse
PI: Pearl Chiu, Ph.D.
PI: Stephen LaConte, Ph.D.
E-mail: pchiu@cpu.bcm.edu and E-mail: slaconte@cpu.bcm.edu
Bupropion Plus Varenicline Treatment: Smoking Cessation (Project Two-2-Quit Conducted at MD Anderson Cancer Center)
Dates: 2008 - 2013
Sponsor: National Institute on Drug Abuse and Pfizer Pharmaceutical Co.
PI: Paul M. Cinciripini, Ph.D.
Co-PI: Maher Karam-Hage, M.D.
E-mail: pcinciri@mdanderson.org and E-mail: karamhag@bcm.edu
Target Validation Core Rats
Dates: Sep. 27, 2001 - Aug. 31, 2016
Sponsor: National Institute on Alcohol Abuse
PI: Therese Kosten, Ph.D.
E-mail: tkosten@bcm.edu
Genomic, Neural, Preclinical Analyses for Smoking Cessation
Dates: Apr. 1, 2011 - Mar. 30, 2014
Sponsor: Helis Medical Research Foundation
Co-PI: John Dani, Ph.D.
Co-PI: Thomas Kosten, M.D.
Co-PI's: M. DeBiasi, PH.D., R. De La Garza, II, Ph.D., D. Nielsen, PH.D.,
R. Salas, Ph.D., S. Scherer, Ph.D.
E-mail: jdani@bcm.edu and E-mail: kosten@bcm.edu
Mechanisms of Action and Effects of Ghrelin Mimetics in Patients with CACS
Dates: Jan. 1, 2012 - Jan. 1, 2013
Sponsor: Veterans Affairs Medical Center
PI: Jose Garcia, M.D., Ph.D.
Co-PI: Ramiro Salas, Ph.D.
E-mail: jgarcia1@bcm.edu and E-mail: rsalas@bcm.edu
Modafinil + Escitalopram for Cocaine Addiction
Dates: Sep. 1, 2009 - Aug. 31, 2012
Sponsor: National Institute on Drug Abuse
PI: Richard De La Garza, II, Ph.D.
E-mail: rg12@bcm.edu
Rivastigmine and Huperzine A as Potential Treatments for Cocaine Addiction
Dates: Jul. 1, 2009 - Jun. 30, 2013
Sponsor: National Institute on Drug Abuse
PI: Richard De La Garza, II, Ph.D.
E-mail: rg@bcm.edu
Rivastigmine as a Treatment for Methamphetamine Dependence
Dates: Jul. 1, 2008 - Jun. 30, 2012
Sponsor: National Institute on Drug Abuse
PI: Richard De La Garza, II, Ph.D.
E-mail: rg12@bcm.edu
Varenicline as a Treatment for Methamphetamine Dependence
Dates: Jul. 1, 2009 - Jun. 30, 2012
Sponsor: National Institute on Drug Abuse
PI: Richard De La Garza, II, Ph.D.
E-mail: rg@bcm.edu
Exercise as a Treatment for Cocaine Dependence
Dates: Aug. 1, 2011 - Jul. 31, 2013
Sponsor: National Institute on Drug Abuse
PI: Richard De La Garza, II, Ph.D.
Co-PI: Colin N. Haile, Ph.D.
E-mail: rg12@bcm.edu and E-mail: chaile@bcm.edu
The Use of Remote Physiological Monitoring Using Bioharness in Cocaine-dependent Participants
Dates: Jul. 1, 2011 - Jul. 30, 2012
Sponsor: National Institute on Drug Abuse
PI: Richard De La Garza, II, Ph.D.
Co-PI: J.H. Yoon, Ph.D.
E-mail: rg12@bcm.edu and E-mail: jiny@bcm.edu
Copper Chelators for the Treatment of Cocaine Dependence: Behavioral and Neurochemical Effects in Rats
Dates: Jul. 1, 2011 - Jun. 30, 2012
Sponsor: Junior Faculty Seed Funding Award
PI: Colin Haile, Ph.D.
E-mail: chaile@bcm.edu
Temporal Calibration of Motor Sensory Systems
Dates: 2007 - 2012
Sponsor: National Institutes of Health (NINDS)
PI: David Eagleman, Ph.D.
E-mail: eagleman@bcm.edu
Synesthesia: From Genes to Neural Networks
Dates: 2011 - 2013
Sponsor: Guggenheim Foundation
PI: David Eagleman, Ph.D.
E-mail: eagleman@bcm.edu
The Neurobiological Effects of Narrative on Empathy
Dates: 2011 - 2012
Sponsor: Defense Advanced Research Projects Agency
PI: David Eagleman, Ph.D.
E-mail: eagleman@bcm.edu
Neurobehavioral Assessment of Interpersonal Functioning in PTSD
Dates: Oct. 1, 2009 - Sep. 30, 2012
Sponsor: VA and Rehabilitation Research & Development
PI: Brooks King-Casas, Ph.D.
E-mail: bkc@cpu.bcm.edu
Sex Differences in Vulnerability to Cocaine Addiction
Dates: Jul. 1, 2008 - Jun. 30, 2012
Sponsor: National Institutes of Health and National Institute on Drug Abuse
PI: Therese Kosten, Ph.D.
Co-PI: David Nielsen, Ph.D.
E-mails: tkosten@bcm.edu and nielsen@bcm.edu
Human Methamphetamine Vaccine: Translational Avante Garde Award
Dates: Sep. 30, 2011 - Aug. 31, 2016
Sponsor: National Institute on Drug Abuse
PI: Thomas R. Kosten, M.D.
E-mail: kosten@bcm.edu
Innovative Multidisciplinary Education: The Statistical Genetics of Addiction
Dates: Apr. 1, 2011 - Mar. 31, 2012
Sponsor: National Institutes of Health and National Institute on Drug Abuse
PI: Thomas R. Kosten, M.D.
E-mail: kosten@bcm.edu
Developing Immunotherapeutics for Methamphetamine Abuse
Dates: Aug. 1, 2009 - Jul. 31, 2012
Sponsor: National Institute on Drug Abuse
PI: Thomas Kosten, M.D.
E-mail: kosten@bcm.edu
Doxazosin and Nepicastat Outpatient Cocaine Trials
Dates: Sep. 1, 2009 - May 31, 2014
Sponsor: National Institute on Drug Abuse
PI: Thomas Kosten, M.D.
E-mail: kosten@bcm.edu
Multisite Controlled Trial of Cocaine Vaccine (1 of 6) Lead Site/Houston
Dates: Sep. 15, 2008 - Jun. 30, 2013
Sponsor: National Institute on Drug Abuse
PI: Thomas Kosten, M.D.
E-mail: kosten@bcm.edu
Stimulant Pharmacotherapy: Noradrenergic Targets
Dates: Sep. 27, 2004 - May 31, 2014
Sponsor: National Institute on Drug Abuse
PI: Thomas Kosten, M.D.
E-mail: kosten@bcm.edu
Preventing Aggression in Veterans with Dementia
Dates: Mar. 1, 2011 - Feb. 28, 2015
Sponsor: VA Health Science Research & Development
PI: Mark Kunik, M.D.
Co-PI: Melinda Stanley, Ph.D.
E-mail: mkunik@bcm.edu and E-mail: mstanley@bcm.edu
Neurorehabilitation: Neurons to Networks
Dates: Jul. 2009 - Jun. 2013
Sponsor: VA Rehabilitation Research and Development
PI: Harvey Levin, Ph.D.
Methods of Optimal Depression Detection in Parkinson's
Dates: Feb. 12, 2010 - Apr. 30, 2012
Sponsor: National Institute of Mental Health
PI: Laura Marsh, M.D.
E-mail: laura.marsh2@va.gov
Adjunctive IV Ketamine in Treatment-Resistant Depression
Dates: Sep. 5, 2009 - Aug. 14, 2013
Sponsor: NARSAD, Independent Investigator Award
PI: Sanjay J. Mathew, M.D.
E-mail: sjmathew@bcm.edu
Optimization of IV Ketamine in Treatment-Resistant Depression
Dates: Jul. 23, 2009 - Apr. 30, 2013
Sponsor: National Institute of Mental Health
PI: Sanjay J. Mathew, M.D.
E-mail: sjmathew@bcm.edu
Efficacy and Tolerability of Riluzole in Treatment-Resistant Depression
Dates: Aug. 1, 2010 - Oct. 4, 2014
Sponsor: National Institute of Mental Health
PI: Sanjay J. Mathew, M.D.
E-mail: sjmathew@bcm.edu
Clinical Research Education for Drug Abuse Professionals
Dates: Mar. 1, 2011 - Feb. 29, 2016
Sponsor: National Institute on Drug Abuse
PI: Thomas Newton, M.D.
E-mail: tnewton@bcm.edu
An ACE Inhibitor as a Treatment for Methamphetamine Dependence
Dates: May 1, 2008 - Apr. 30, 2013
Sponsor: National Institute on Drug Abuse
PI: Thomas Newton, M.D.
E-mail: tnewton@bcm.edu
N-acetylcysteine as a Treatment of Methamphetamine Dependence
Dates: 2009 - 2012
Sponsor: National Institute on Drug Abuse
PI: Thomas Newton, M.D.
E-mail: tnewton@bcm.edu
Neurorehabilitation: Neurons to Networks Center for Rehabilitation Research
Dates: Aug. 20, 2005 - Jun. 30, 2014
Sponsor: National Institute on Drug Abuse
PI: David A. Nielsen, Ph.D..
E-mail: nielsen@bcm.edu
CHOICES+: Preconception Approach to Reducing Alcohol and Tobacco-Exposed Pregnancy
Dates: Sep. 30, 2010 - Sep. 29, 2012
Sponsor: UT-Austin & Centers for Disease Control and Prevention
PI: Britta Ostermeyer, M.D.
E-mail: brittao@bcm.edu
Functional Imaging of the Habenula in Tobacco Smokers
Dates: Mar. 1, 2011 - Feb. 29, 2012
Sponsor: National Institute on Drug Abuse
PI: Ramiro Salas, Ph.D.
E-mail: rsalas@bcm.edu
Role of Habenula in Tobacco Addiction
Dates: Aug. 1, 2010 - May 31, 2014
Sponsor: National Institutes of Health
PI: Ramiro Salas, Ph.D.
E-mail: rsalas@bcm.edu
Randomized, Comparative Study of the Efficacy and Safety of BMS-820836 in
Patients with Treatment Resistant Major Depression
Dates: Jul. 31, 2011 - Jul. 30, 2012
Sponsor: Bristol Myers Squibb
PI: Asim Shah, M.D.
E-mail: aashah@bcm.edu
Co-PI: Sanjay Mathew, M.D.
E-mail: sjmathew@bcm.edu
Assess the Safety and Tolerability of BMS-820836 in Patients with Treatment
Resistant Depression
Dates: Jul. 27, 2011 - Jul. 26, 2013
Sponsor: Bristol Myers Squibb
PI: Asim Shah, M.D.
E-mail: aashah@bcm.edu
Co-PI: Sanjay Mathew, M.D.
E-mail: sjmathew@bcm.edu
Efficacy and Safety of JNJ-26489112 in Adult Subjects With Major Depressive Disorder
Dates: Dec. 22, 2010 - Mar. 15, 2012
Sponsor: Johnson & Johnson
PI: Asim Shah, M.D.
E-mail: aashah@bcm.edu
CBT for Late-Life GAD in Primary Care: Enhancing Outcomes and Translational Value
Dates: Sep. 1, 1996 - Apr. 30, 2013
Sponsor: National Institute of Mental Health
PI: Melinda Stanley, Ph.D.
E-mail: mstanley@bcm.edu
Maternal Brain and Behavioral Responses to Infant Cues in Cocaine Exposed Mothers
Dates: Apr. 15, 2010 - Jan. 31, 2015
Sponsor: National Institute on Drug Abuse
PI: Lane Strathearn, M.D., Ph.D.
E-mail: lanes@bcm.edu
Intranasal Oxytocin: A Neuropharmacological Intervention for Maternal Neglect?
Dates: Jul. 1, 2010 - Jun. 30, 2015
Sponsor: National Institute of Health
PI: Lane Strathearn, M.D., Ph.D.
E-mail: lanes@bcm.edu
Neuroimaging the Impact of Treatment on Neural Substrates of Trust in PTSD
Dates: Jan. 1, 2011 - Dec. 31, 2012
Sponsor: VA Rehabilitation Research & Development
PI: Wright Williams, Ph.D.
E-mail: wright.williams@va.gov
Targeting the Noradrenergic System for Developing Novel Medications for Smoking Cessation
Dates: Jul. 1, 2011 - Jun. 30, 2012
Sponsor: Caroline Wiess Law Fund/ARCO Foundation
PI: J.H. Yoon, Ph.D.
E-mail: jiny@bcm.edu